Ben Sasse, Terminal Cancer, and the 60 Minutes Interview That Stopped America in Its Tracks — A Complete Guide
I'll be honest — when I first saw the headline about Ben Sasse appearing on 60 Minutes to talk about his cancer diagnosis, I hesitated. Politics is exhausting right now, and the thought of another former politician making a media appearance felt like it might just be noise. But then I actually watched the interview. And I sat there in silence for a few minutes afterward, just thinking.
Because this was not a political story. This was a human story — about a 54-year-old man who was told he had three to four months to live, who is currently outliving that prognosis thanks to an experimental drug, and who is using the time he has left to say things he genuinely believes matter. Things about family, faith, community, artificial intelligence, and a Congress he thinks has completely lost the plot.
If you searched for "Ben Sasse," "Ben Sasse cancer," "Ben Sasse illness," or "Ben Sasse 60 Minutes Scott Pelley" — you are in exactly the right place. I'm going to walk you through everything: who he is, what happened to him, what he said on that broadcast, what the experimental drug is that's giving him extra time, and why, even if you've never followed Nebraska politics a day in your life, his story is worth your full attention.
Who Is Ben Sasse? A Background for People Who Don't Follow Politics
Let me give you a genuine, honest picture of who this man is — because he's more interesting and more complicated than a simple "Republican senator from Nebraska" headline suggests.
The Early Life: From Small-Town Nebraska to Harvard and Yale
Benjamin Eric Sasse was born on February 22, 1972, in Plainview, Nebraska — a small town of a few hundred people. He grew up in a family that valued education, hard work, and community. His father was a high school teacher and football coach. That background — small-town midwestern, academic household — shaped him in ways that you can still hear in how he talks.
He was, to put it gently, an overachiever from the start. He was valedictorian of his high school class in Fremont, Nebraska. He went to Harvard College, graduating in 1994 with a degree in government. He studied at Oxford. He earned a Master of Arts from St. John's College. And then, in 2004, he completed a PhD in history from Yale University. That's Harvard, Oxford, and Yale on one résumé. The man is not short on academic credentials.
Before Politics: Government, Academia, and Midland University
Before he ever ran for office, Sasse had already lived a full professional life. He worked in the private sector, did a stint at McKinsey & Company (the famous consulting firm), and served in the U.S. Department of Health and Human Services under President George W. Bush, rising to Assistant Secretary. He then returned to academia, becoming president of Midland University — a small Lutheran college in Fremont, Nebraska — in 2010. He served there until 2014, helping stabilise the institution financially and academically.
The Senate Career: 2015 to 2023
In 2014, Sasse ran for the U.S. Senate seat from Nebraska. He won convincingly, took office in January 2015, and immediately started doing something unusual for a Republican senator in that era: he thought for himself.
He was openly critical of Donald Trump — before Trump was president, during his presidency, and after. When Trump's supporters stormed the Capitol on January 6, 2021, Sasse condemned it sharply and voted to convict Trump in the subsequent Senate impeachment trial. He did this as a Republican, in Nebraska, knowing it would cost him politically. The Nebraska Republican Party censured him for it. He responded by saying, essentially, that politics "isn't about the weird worship of one dude."
At the same time, he regularly voted with Republican positions on policy — he helped confirm three of Trump's Supreme Court nominees. His bipartisan reputation came not from voting the other way, but from how he talked: honestly, with nuance, without the performative outrage that defines so much of modern political communication. Democratic Senator Mark Warner, who worked with him on the Intelligence Committee, said Sasse "never really thought about things as conservative, liberal — he much more thought about issues as future, past." That is a genuinely unusual thing to be able to say about a politician.
He also wrote two books during this period: The Vanishing American Adult (2017) and Them: Why We Hate Each Other—and How to Heal (2018). Both were serious, readable, non-partisan arguments about the state of American culture. He had a bigger platform in mind than just serving Nebraska.
The University of Florida Chapter
In January 2023, Sasse resigned from the Senate — with four years still left on his second term — to become the 13th president of the University of Florida. It was a controversial move. Some faculty and students objected to his positions on social issues. The faculty senate passed a no-confidence resolution. But he took the job anyway, with a $1 million annual salary, and began an ambitious agenda he framed around the "future of work."
His presidency lasted 17 months. In July 2024, he resigned — citing the worsening health of his wife, Melissa, who had suffered strokes in 2007 and had recently been diagnosed with epilepsy and was experiencing new memory issues. Reports later suggested there were additional tensions with the board of trustees, and questions were raised about Sasse's office spending habits during his time there. He remained at the university as a professor after stepping down.
And then, in December 2025, everything changed again.
Ben Sasse's Cancer Diagnosis: What Happened and When
This is the part that genuinely stopped me in my tracks when I first read it. Not because cancer stories are unusual in public life — they're not — but because of the specific details of how this unfolded, and how Sasse has chosen to respond to them.
The December 2025 Diagnosis
In December 2025, Ben Sasse was diagnosed with stage four metastatic pancreatic cancer. He disclosed this publicly shortly after receiving the diagnosis.
Let me explain what stage four metastatic pancreatic cancer means, because it's important context. Pancreatic cancer is, statistically, one of the most lethal cancers in existence. Only about 13% of people diagnosed with it are alive five years later. "Stage four" means the cancer has spread beyond the pancreas to other parts of the body. "Metastatic" means exactly that — it has spread, metastasised, seeded itself in multiple locations. When Sasse was diagnosed, his doctors identified not just pancreatic cancer but four other cancers connected to the original site: in his lymph nodes (lymphoma), vascular system, lungs, and liver.
Imagine planting a dandelion in your garden. By the time you see it, the seeds have already blown into five neighbouring yards. That is essentially what metastatic pancreatic cancer looks like — by the time it is caught and identified, it has already spread beyond surgical reach.
When Sasse's doctors told him his prognosis, they gave him three to four months to live. That was in December 2025. In February 2026, speaking publicly, he confirmed that timeline.
He is still alive, in late April 2026, well past that window. And here's why.
The "Miracle Drug": What Is Daraxonrasib?
Shortly after his diagnosis, Sasse was enrolled in a clinical trial at MD Anderson Cancer Center in Houston — one of the most respected cancer treatment facilities in the world. The drug he is taking is called daraxonrasib, developed by a Silicon Valley biotechnology company called Revolution Medicines.
Let me explain how this drug works in plain English, because it's genuinely fascinating. In about 90% of pancreatic cancer cases, a defective gene called RAS sends a constant signal to cells telling them to grow uncontrollably. Think of it like a gas pedal stuck to the floor with no brake. Most cancer drugs have struggled to target this specific gene effectively for decades. Daraxonrasib is designed to block that signal — to cut the wire between the defective gene and the cells it's telling to multiply. It's an oral drug — you take a pill, not an infusion.
The results in Sasse's case have been extraordinary. He has described a 76% reduction in tumor volume over the four months since he started treatment. His pain levels — which at diagnosis required 55 milligrams of morphine daily — have been reduced by roughly 80%, with his morphine dose down to about 30 milligrams per day.
The drug is not a cure. Sasse has been clear about that. The cancer is still there. It has spread too widely for surgery. But the drug appears to be controlling it — buying time that the doctors did not originally think he would have. Revolution Medicines confirmed in a Phase 3 clinical trial this month that patients on daraxonrasib survived a median of 13.2 months, compared to 6.7 months on standard chemotherapy. In a disease with a five-year survival rate of 13%, nearly doubling the survival window is, by any medical standard, remarkable.
The Side Effects Are Brutal
I want to be honest about this because Sasse himself has not shied away from it. RAS proteins exist all over the human body, not just in cancer cells. So when daraxonrasib blocks RAS signals, it also affects healthy tissue — particularly skin. The result is a severe rash that prevents the skin from healing properly, causing bleeding from facial tissue and other areas. Sasse has described his face as "bloody" and "bubbling." He says the sensation is "nuclear." He jokes — with characteristic dark humour — about how often he visits the pharmacy.
This is a man who is taking a drug that is visibly tearing up his face in exchange for extra months of life. And he has said, repeatedly, that he would do it again without hesitation. That tells you something about the man.
Ben Sasse on 60 Minutes: The April 26, 2026 Interview With Scott Pelley
Now let's get into the interview itself — because this is what brought so many people to their phones and laptops yesterday, searching for who this person is and what he said.
What Is 60 Minutes?
For anyone who doesn't know — and genuinely, no judgement, because not everyone grew up watching Sunday night CBS News in America — 60 Minutes is essentially the gold standard of long-form television journalism. It has been airing since 1968. Its format is simple: deeply reported, face-to-face interviews on significant topics, usually about 15–20 minutes per segment. It is where major figures — politicians, business leaders, whistleblowers, scientists — go when they want to have a serious, substantive conversation with a large audience.
Scott Pelley, who conducted the Sasse interview, has been a 60 Minutes correspondent since 2004. He is one of the most decorated journalists in the programme's history. When Sasse agreed to sit down with Pelley, it was a deliberate choice — he wanted a serious interview, not a softball appearance. He wanted to say things that would be heard by millions of people who might not follow his Twitter account or his podcast.
The Broadcast: April 26, 2026
The interview aired on the CBS Television Network at 7:00 PM ET/PT on Sunday, April 26, 2026. That is today — or was yesterday, depending on when you're reading this. Following the 60 Minutes segment, CBS aired a special edition of Things That Matter — an extended version of the interview, plus a town hall moderated by Pelley that included questions from audience members dealing with their own serious health challenges and members of the faith community. The extended content was also available on Paramount+ and CBS News's YouTube channel.
What Did Ben Sasse Actually Say?
Here is my honest summary of the most significant things Sasse communicated — because his words deserve to be understood, not just summarised in a headline.
On His Cancer and His Faith
Sasse attributed his continued survival to three things: "providence, prayer, and a miracle drug." He was clear that he believes God has given him extra time — and equally clear that he is not using that time to wallow or to rage. He said he has become more honest with himself since the diagnosis. "The lie I want to tell myself is that I'm the center of everything. And I'm going to be around forever. And I can work harder, and store up enough, that I can atone for my own brokenness. I can't," he told Pelley. He added that he hates cancer — but is also, strangely, grateful for it.
His faith is genuinely central to how he is navigating this. He has spoken about the late pastor Tim Keller — who also died of pancreatic cancer — and said he would not wish this disease on anyone, but would not want to return to a time before the clarity and honesty it has forced on him.
On Congress and American Politics
Sasse was characteristically blunt. He said neither political party has serious ideas about where America is going in 2030 or 2050. He argued that the introduction of cameras "everywhere in Washington" has turned the Senate into a performance space rather than a deliberative body. "The Senate should be plodding, and steady, and boring, and trustworthy," he said. "That's not what it is right now."
He was particularly sharp on artificial intelligence and the future of work. "We've never lived in a world where 22-year-olds couldn't assume that the work they did, they would be able to do until death or retirement. And we're never going to have that world again," he said. His argument: the biggest disruption facing America is the technological disruption of employment, and Congress doesn't even know how to begin having that conversation.
On Community and What Actually Matters
Perhaps the most resonant part of his interview — the part I keep coming back to — was his argument about community. He believes that America's political dysfunction is a symptom of a deeper cultural problem: that people have substituted their political tribe for genuine local community. "We are sacrificing a lot of our national politics to weird folks who want their main community to be their political tribe at a federal level," he said, "and that should be like the ninth thing, or the fifteenth thing you care about, not the first or second."
And on the question of political titles versus personal relationships, he said something that I think will be quoted for years. When Pelley noted that many senators would find it devastating to leave office, Sasse said: "The best thing you can do is be called dad or mom, lover, neighbor, friend. Governor? Senator? House member? It's a great way to serve. It should be your eleventh calling, or maybe sixth, but never top."
On Living on a Deadline
Maybe the deepest moment of the interview came when Sasse talked about what terminal illness actually does to the way you live. He said cancer has forced him to stop lying to himself — to face the things that were always true about his own limitations and mortality, but that it's easy to avoid when you feel invincible. "Cancer has forced me to tell myself the truth," he said. He sees the compressed timeline not only as a loss, but as a strange kind of clarity that most people never experience until it is too late to act on.
Why Ben Sasse's Story Matters Beyond Politics
I want to share my personal take here, because I think this story deserves more than a medical update and a political recap.
We live in an era where public figures are almost always performing. Every statement is calibrated. Every appearance is managed. The goal is usually to avoid saying anything that can be clipped and weaponised. Ben Sasse, sitting with a face bleeding from a clinical trial drug, with his doctors' three-to-four-month prognosis already overrun, has essentially stopped performing. There is nothing left to manage. There is no next election, no fundraiser, no board to impress. There is just a man saying what he actually thinks, to as many people as will listen, for however long he has left.
That is rare. And it is, in my opinion, why the interview hit people so hard. Not because Sasse is politically beloved — he isn't, universally. But because he represents something we rarely see in the public square: unfiltered honesty from someone who genuinely has nothing left to lose by telling the truth.
He is also shining a spotlight, purely by virtue of his public platform, on the experimental drug daraxonrasib — and by extension, on the 67,000 Americans who will be diagnosed with pancreatic cancer this year and who currently have almost no good treatment options. He has spoken publicly about wanting the FDA to decentralise more treatment decisions to individual patients and their doctors, particularly for terminal diagnoses where time is the only currency that matters. That is a policy argument with real stakes, made by someone with real skin in the game.
A Timeline of Ben Sasse's Life: From Nebraska to 60 Minutes
| Year | Event |
|---|---|
| 1972 | Born in Plainview, Nebraska |
| 1994 | Graduated Harvard College (BA, Government) |
| 2004 | Received PhD in History from Yale University |
| 2004–2007 | Served as Assistant Secretary at U.S. Department of Health and Human Services |
| 2010–2014 | President of Midland University, Fremont, Nebraska |
| 2015 | Sworn in as U.S. Senator from Nebraska (Republican) |
| 2017 | Published The Vanishing American Adult |
| 2018 | Published Them: Why We Hate Each Other—and How to Heal |
| 2020 | Re-elected to Senate by larger margin than Donald Trump in Nebraska |
| Jan. 6, 2021 | Condemned Capitol riot; later voted to convict Trump in Senate impeachment trial |
| January 2023 | Resigned from Senate to become President of University of Florida |
| July 2024 | Resigned from University of Florida presidency citing wife Melissa's health |
| December 2025 | Diagnosed with stage four metastatic pancreatic cancer; given 3–4 months to live |
| Early 2026 | Enrolled in clinical trial at MD Anderson for daraxonrasib (Revolution Medicines) |
| April 10, 2026 | Disclosed 76% tumor reduction in NYT interview; Revolution Medicines Phase 3 trial results announced |
| April 26, 2026 | Appeared on CBS 60 Minutes with Scott Pelley; CBS Things That Matter town hall also aired |
Conclusion: Ben Sasse's Last Lessons — and Why They Land So Hard
I started this article by telling you I hesitated when I heard about this interview. I want to close by telling you why I am glad I didn't skip it.
Ben Sasse is a complicated figure. His political record is genuinely mixed — praised by some for intellectual independence, criticised by others for the spending controversies at Florida, the abrupt exits from both the Senate and the university presidency, and policy positions that not everyone agrees with. He is not a saint. He is not without his contradictions. He would probably be the first to tell you that.
But what he is doing right now — choosing to spend some of his remaining time and energy saying publicly what he believes, pointing people toward family and community and local life over tribal politics, drawing attention to an experimental drug that might one day save tens of thousands of lives a year — is genuinely admirable. And his willingness to do it with a bleeding face, over a morphine regimen, past a survival deadline that his own doctors did not expect him to clear, is the kind of human determination that cuts through all the noise.
He said in the interview: "We're all mortal. We're all on the clock. We're all going to be pushing up daisies eventually, and I think wisdom requires us to grapple with our death and our finitude early." Most of us won't get the clarity of a terminal diagnosis to force that reckoning. But maybe we don't need to. Maybe watching Ben Sasse on a Sunday night on 60 Minutes is enough to prompt the question: what would I do with my time if I really, truly understood it was running out?
That, to me, is the most powerful thing a 54-year-old man with stage four pancreatic cancer can give us. And I think it's worth more than any political speech he ever gave.
— Krishna Gupta
SEO Expert & Content Writer
guide-vera.com
Frequently Asked Questions (FAQs)
Who is Ben Sasse?
Ben Sasse is an American politician, academic, and author who represented Nebraska in the United States Senate as a Republican from January 2015 to January 2023. Born on February 22, 1972, in Plainview, Nebraska, he holds a PhD in history from Yale University and previously served as president of Midland University in Nebraska. During his Senate career, he became known as an independent-minded conservative who was openly critical of Donald Trump, voting to convict him in both Senate impeachment trials. In 2023, he resigned from the Senate to become the 13th president of the University of Florida, a role he left in July 2024 citing his wife Melissa's health challenges. In December 2025, he publicly announced a diagnosis of stage four metastatic pancreatic cancer.
What illness does Ben Sasse have?
Ben Sasse was diagnosed with stage four metastatic pancreatic cancer in December 2025. At diagnosis, doctors identified that the cancer had spread beyond the pancreas to five areas of his body, including the lungs, liver, vascular system, and lymph nodes. He was given an initial life expectancy of three to four months. Pancreatic cancer has one of the lowest survival rates of all major cancers — only about 13% of patients survive five years after diagnosis. Sasse enrolled in a clinical trial at MD Anderson Cancer Center for an experimental drug called daraxonrasib, developed by Revolution Medicines, which has produced a reported 76% reduction in his tumor volume over the first four months of treatment. He has described living on what he calls "extended time" — surviving significantly beyond his initial prognosis, attributing his continued life to "providence, prayer, and a miracle drug."
What did Ben Sasse say on 60 Minutes with Scott Pelley in 2026?
Ben Sasse appeared on CBS 60 Minutes on April 26, 2026, in a wide-ranging interview with correspondent Scott Pelley. In the interview, Sasse covered several major themes. On his illness: he credited "providence, prayer and a miracle drug" (the experimental drug daraxonrasib) for extending his life beyond his original three-to-four-month prognosis, and said the diagnosis forced him to stop lying to himself about his own limitations. On Congress: he argued that neither political party has serious ideas about America's future in 2030 or 2050, and said the Senate has become a performance space focused on sound bites rather than deliberation. On artificial intelligence: he warned that the disruption of work by AI is the most important issue Congress is failing to address. On community: he argued that Americans have mistakenly made national politics their primary identity instead of investing in family and local community. He also said political titles like "senator" should rank no higher than sixth or eleventh among a person's callings — never first. The interview was followed by a special edition of CBS Things That Matter, which included an extended conversation and a town hall moderated by Pelley.
What is the experimental drug Ben Sasse is taking for pancreatic cancer?
The drug Ben Sasse is taking is called daraxonrasib, developed by the Silicon Valley biotechnology company Revolution Medicines. It is an oral medication — taken as a pill — that works by blocking a defective gene called RAS, which in approximately 90% of pancreatic cancer cases sends a continuous signal to cells instructing them to grow uncontrollably. By blocking that signal, daraxonrasib interferes with tumor growth at a molecular level. Sasse is participating in a clinical trial for the drug at MD Anderson Cancer Center in Houston. In his case, the drug has produced a reported 76% reduction in tumor volume over four months, with his daily pain levels reduced by roughly 80%. Revolution Medicines published positive Phase 3 trial results in April 2026, showing that patients on daraxonrasib survived a median of 13.2 months versus 6.7 months on standard chemotherapy. The drug had not yet received full FDA approval as of the time of writing, though Phase 3 results significantly accelerate the approval pathway. The drug causes severe skin side effects, including facial bleeding and rashes, because RAS proteins are present throughout the body, not only in cancer cells.
Who is Scott Pelley, and why did he interview Ben Sasse?
Scott Pelley is one of the most experienced and decorated journalists at CBS News. He has been a correspondent for 60 Minutes since 2004 and has won a significant share of the major journalism awards earned by the programme during his tenure. He is widely regarded as one of the most trusted interviewers in American broadcast journalism. Sasse chose to give his major public interview about his cancer diagnosis, his political reflections, and his "last lessons" to 60 Minutes and specifically to Pelley because it is a platform known for serious, substantive, long-form journalism rather than political theatre. The 60 Minutes interview aired on Sunday, April 26, 2026, and was accompanied by a special extended edition of CBS's Things That Matter programme, also moderated by Pelley, which included a town hall with audience members facing their own health challenges and members of the faith community.